GO:1902306 negative regulation of sodium ion transmembrane transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1902306 describes any process that stops, prevents, or reduces the frequency, rate, or extent of sodium ion transmembrane transport.
• It is a biological_process term that sits at the intersection of ion channel regulation, epithelial physiology, and neuronal excitability [1,3].
• Key molecular players include the epithelial sodium channel (ENaC), Na+/K+-ATPase isoforms, and accessory proteins that modulate their activity [1,6].
• Dysregulation of this process is linked to cystic fibrosis airway disease, neuroinflammation, and disorders of glycosylation affecting ion channels [2,5,6,7].
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect causal roles of candidate regulators [1,6].
• EDITGENE provides end-to-end CRISPR cell model and library screening services to study GO:1902306-related genes.
Description
Sodium ion transmembrane transport is fundamental to cellular excitability, fluid balance, and nutrient uptake. The Gene Ontology term GO:1902306, negative regulation of sodium ion transmembrane transport, captures the regulatory processes that dampen or inhibit this flux. This term is critical for understanding how cells fine-tune sodium movement in response to physiological signals or pathological insults. Researchers studying epithelial sodium channels (ENaC) have shown that anionic phospholipids can acutely regulate channel activity, providing a paradigm for negative regulation at the membrane level. Similarly, the Na+/K+-ATPase alpha-2 isoform has been implicated in neuroinflammatory responses, highlighting the importance of sodium transport regulation in the nervous system. At the molecular level, negative regulation can occur through direct channel inhibition, altered trafficking, or changes in the electrochemical gradient. For example, negative charges in transmembrane segments of sodium channels are critical for gating, and mutations can disrupt this regulation. Accessory proteins such as CFTR and molecular adaptors dynamically regulate ion channels, influencing sodium transport indirectly. Glycosylation and sialylation of ion channels also modulate their function, adding another layer of regulation. Understanding GO:1902306 is essential for researchers in nephrology, pulmonology, neuroscience, and drug discovery. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a comprehensive overview of the mechanisms, genes, diseases, and research methods associated with this term.
negative regulation of sodium ion transmembrane transport At A Glance
| GO ID | GO:1902306 |
|---|---|
| GO term | negative regulation of sodium ion transmembrane transport |
| Ontology | biological_process |
| Synonym | down regulation of sodium ion membrane transport; inhibition of sodium ion transmembrane transport; negative regulation of sodium ion membrane transport |
| Major function | Inhibits or reduces sodium ion flux across membranes, modulating excitability, fluid balance, and signaling. |
| Related cellular components | Plasma membrane, epithelial sodium channel complex, Na+/K+-ATPase complex |
| Related molecular functions | Sodium channel inhibitor activity, ion channel binding, ATPase regulator activity |
| Associated diseases | Cystic fibrosis, neuroinflammation, disorders of glycosylation, hypertension |
| Research methods | Patch-clamp electrophysiology, CRISPR knockout, RNA-seq, proteomics |
What Is GO:1902306?
GO:1902306, negative regulation of sodium ion transmembrane transport, is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of sodium ion transmembrane transport. It encompasses molecular events that inhibit the movement of sodium ions across biological membranes, including direct channel blockade, reduced channel expression, altered gating properties, and changes in driving forces. This term is a biological_process in the Gene Ontology and is distinct from positive regulation or general regulation of sodium transport.
Why Is negative regulation of sodium ion transmembrane transport Important in Cell Biology?
GO:1902306 is important because sodium ion transmembrane transport is a cornerstone of cellular physiology, and its negative regulation prevents excessive sodium influx that can lead to cellular toxicity, arrhythmias, and impaired fluid clearance. In epithelial tissues, negative regulation of ENaC is critical for maintaining airway surface liquid and blood pressure. In the nervous system, dysregulated sodium transport contributes to neuroinflammation and neuronal damage. Moreover, many pathogens and drugs target these regulatory pathways, making them attractive therapeutic targets. Understanding this process at the molecular level can reveal new strategies for treating cystic fibrosis, hypertension, and neurological disorders [5,8].
• Maintains electrolyte homeostasis by preventing excessive sodium influx.
• Regulates blood pressure through ENaC inhibition in the kidney.
• Controls airway surface liquid volume; dysfunction leads to cystic fibrosis [5,8].
• Modulates neuronal excitability and protects against neuroinflammation.
• Influences cardiac action potentials and arrhythmia risk.
• Affects drug efficacy, e.g., pyrethroid insecticides target sodium channel gating.
• Glycosylation changes can alter ion channel regulation, linking to congenital disorders [2,7].
• Provides targets for diuretics and antihypertensive drugs.
• Relevant to cancer biology via altered ion transport in tumor cells.
• Key for understanding basic membrane biology and signal transduction.
What Happens During negative regulation of sodium ion transmembrane transport?
Initiation by Regulatory Signals
In simple terms: The process starts when a cell receives a signal to reduce sodium entry.
Negative regulation of sodium ion transmembrane transport is initiated by diverse signals, including hormones, mechanical stress, or changes in membrane lipid composition. For instance, anionic phospholipids can acutely inhibit ENaC activity, serving as a rapid regulatory mechanism. In the vascular wall, changes in chloride and bicarbonate concentrations can indirectly influence sodium transport. These initial signals often converge on ion channels or transporters, triggering conformational changes or post-translational modifications that reduce sodium flux.
Direct Channel Inhibition or Gating Modification
In simple terms: The channel itself is blocked or its opening is made harder.
A primary mechanism is direct inhibition of sodium channels. For example, negative charges in transmembrane segment 1 of domain II of the cockroach sodium channel are critical for gating, and mutations that alter these charges can impair channel opening, effectively reducing sodium transport. Similarly, pyrethroid insecticides bind to sodium channels and modify gating, often leading to negative regulation of normal flux. In mammalian systems, ENaC activity can be reduced by changes in membrane phospholipids.
Trafficking and Membrane Retention
In simple terms: The cell removes sodium channels from the surface or keeps them inside.
Negative regulation can also occur by reducing the number of sodium channels at the plasma membrane. Molecular adaptors such as CFTR-associated proteins dynamically regulate ion channel trafficking. Competitive interactions between adaptors can retain channels in intracellular compartments, decreasing sodium transport. This mechanism is particularly relevant in epithelial cells, where ENaC surface expression is tightly controlled to maintain fluid balance [1,5].
Post-translational Modifications and Glycosylation
In simple terms: Chemical tags on the channel change how well it works.
Glycosylation and sialylation of ion channels can modulate their function and stability. Altered sialylation affects ion channel gating and surface expression, thereby influencing sodium transport. SLC10A7, a gene involved in O-GalNAc glycosylation, regulates calcium homeostasis and potentially impacts ion transport. These modifications provide a layer of negative regulation that can be disrupted in disease states such as congenital disorders of glycosylation [2,7].
Ion Gradient and ATPase Regulation
In simple terms: The pump that maintains sodium gradients is slowed down.
The Na+/K+-ATPase establishes the sodium gradient necessary for transport. Negative regulation of this pump, for example via the alpha-2 isoform in neuroinflammation, can reduce the driving force for sodium entry. LPS-induced neuroinflammation is mediated by the alpha-2 Na+/K+-ATPase isoform, and its inhibition can dampen sodium transport. This mechanism links metabolic and inflammatory signals to sodium transport regulation.
Key Genes Involved in GO:1902306 negative regulation of sodium ion transmembrane transport
The following genes and proteins are central to negative regulation of sodium ion transmembrane transport, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SCNN1A | Alpha subunit of ENaC; mediates sodium transport in epithelia | Target for studying ENaC regulation and cystic fibrosis |
| SCNN1B | Beta subunit of ENaC; modulates channel gating | Mutations linked to Liddle syndrome and hypertension |
| SCNN1G | Gamma subunit of ENaC; regulates channel activity | Key for understanding epithelial sodium transport |
| ATP1A2 | Alpha-2 isoform of Na+/K+-ATPase; maintains sodium gradient | Mediates LPS-induced neuroinflammation |
| CFTR | Chloride channel; interacts with ENaC and regulates sodium transport | Dysfunction in cystic fibrosis affects sodium regulation [5,8] |
| SLC10A7 | Involved in O-GalNAc glycosylation and Ca2+ homeostasis | Mutations cause SLC10A7-CDG with ion transport defects |
| TMEM16A | Calcium-activated chloride channel; alternative anion secretion | Modulates sodium transport in cystic fibrosis airways |
| SCN1A | Voltage-gated sodium channel alpha subunit | Gating mutations affect sodium flux; target of insecticides |
| SCN2A | Voltage-gated sodium channel alpha subunit | Neuronal excitability and sodium transport regulation |
| SCN3A | Voltage-gated sodium channel alpha subunit | Expressed in brain; contributes to sodium currents |
| SCN4A | Voltage-gated sodium channel alpha subunit | Muscle excitability; mutations cause channelopathies |
| SCN5A | Voltage-gated sodium channel alpha subunit | Cardiac sodium current; arrhythmia risk |
| SCN8A | Voltage-gated sodium channel alpha subunit | Neuronal sodium transport; epilepsy links |
| SCN9A | Voltage-gated sodium channel alpha subunit | Pain perception; sodium transport regulation |
| SCN10A | Voltage-gated sodium channel alpha subunit | Sensory neuron sodium current |
| SCN11A | Voltage-gated sodium channel alpha subunit | Nociception; sodium transport |
| NEDD4L | E3 ubiquitin ligase; regulates ENaC degradation | Negative regulation of ENaC surface expression |
| SGK1 | Serum/glucocorticoid-regulated kinase; modulates ENaC | Phosphorylates NEDD4L to regulate sodium transport |
How Is negative regulation of sodium ion transmembrane transport Regulated?
Negative regulation of sodium ion transmembrane transport is itself regulated by multiple signaling pathways. The serum/glucocorticoid-regulated kinase (SGK1) phosphorylates NEDD4L, an E3 ubiquitin ligase, thereby reducing ENaC ubiquitination and increasing its surface expression; conversely, dephosphorylation enhances NEDD4L activity and promotes ENaC degradation, leading to negative regulation. Anionic phospholipids can acutely inhibit ENaC, providing a rapid membrane-level control. In the vascular wall, chloride and bicarbonate concentrations influence sodium transport indirectly through changes in pH and membrane potential. Inflammatory signals, such as LPS, activate the alpha-2 Na+/K+-ATPase isoform, which can modulate sodium gradients and affect neuroinflammation. Glycosylation pathways, including O-GalNAc glycosylation mediated by SLC10A7, also impact ion channel function and calcium homeostasis, indirectly affecting sodium transport.
negative regulation of sodium ion transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SCNN1B | Liddle syndrome (hypertension) | Knock-in mouse with gain-of-function mutation; HEK293 overexpression |
| CFTR | Cystic fibrosis | CFTR knockout iPSC-derived airway epithelia; patient-derived organoids |
| ATP1A2 | Neuroinflammation | ATP1A2 knockout microglia; LPS-induced neuroinflammation model |
| SLC10A7 | SLC10A7-CDG | SLC10A7 knockout HeLa; glycosylation profiling |
| SCN5A | Brugada syndrome / arrhythmia | SCN5A knock-in cardiomyocytes; patch-clamp |
Cystic Fibrosis and Airway Disease
In cystic fibrosis, mutations in CFTR lead to defective chloride transport and enhanced ENaC-mediated sodium absorption, causing dehydration of airway surface liquid [5,8]. Negative regulation of sodium transport is impaired, contributing to mucus obstruction and infection. Therapeutic strategies aim to restore anion secretion via TMEM16A or inhibit ENaC to reduce sodium influx. Understanding GO:1902306 is therefore critical for developing correctors and potentiators for cystic fibrosis.
Neuroinflammation and Neurodegeneration
The alpha-2 isoform of Na+/K+-ATPase mediates LPS-induced neuroinflammation, and its dysregulation can lead to altered sodium gradients and neuronal damage. Negative regulation of sodium transport in glial cells may protect against excitotoxicity. Targeting this pathway could offer therapeutic benefits in neuroinflammatory diseases such as Alzheimer's and Parkinson's.
Cardiovascular and Hypertensive Disorders
Sodium transport regulation is central to blood pressure control. ENaC overactivity causes Liddle syndrome, a monogenic form of hypertension, due to loss of negative regulation. In the vascular wall, chloride and bicarbonate transport influence sodium handling and vascular tone. Cardiac sodium channels (e.g., SCN5A) are targets for antiarrhythmic drugs, and their negative regulation affects action potential duration.
Congenital Disorders of Glycosylation
Mutations in SLC10A7 cause a congenital disorder of glycosylation (SLC10A7-CDG) with defects in O-GalNAc glycosylation and calcium homeostasis, which can indirectly affect ion transport including sodium. Altered sialylation and glycosylation of ion channels are known to impact channel function and may contribute to disease pathology.
From negative regulation of sodium ion transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate ENaC? | CRISPR knockout of gene X in epithelial cells; Ussing chamber |
| Does a point mutation alter sodium channel gating? | Point-mutation knock-in of SCN5A in cardiomyocytes; patch-clamp |
| Does overexpression of NEDD4L reduce ENaC surface expression? | Overexpression of NEDD4L in HEK293; biotinylation assay |
| Does SLC10A7 glycosylation affect sodium transport? | Knock-in of tagged SLC10A7; proximity ligation assay |
| Which genes regulate sodium transport in neuroinflammation? | CRISPR library screening in microglia; RNA-seq |
| Can TMEM16A activation compensate for CFTR loss? | Overexpression of TMEM16A in CF airway cells; short-circuit current |
How to Study the negative regulation of sodium ion transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp | Ion channel currents | Measure sodium channel gating and inhibition |
| Ussing chamber | Transepithelial ion transport | Assess ENaC activity in epithelial monolayers |
| CRISPR knockout screen | Gene function loss | Identify negative regulators of sodium transport |
| RNA-seq | Transcript abundance | Profile gene expression changes after knockout |
| Proteomics | Protein abundance and modifications | Detect glycosylation changes in SLC10A7 mutants |
| Surface biotinylation | Membrane protein levels | Quantify ENaC surface expression |
| Fluorescence imaging | Protein localization | Track channel trafficking in live cells |
| Short-circuit current | Net ion flux | Measure CFTR and ENaC function in cystic fibrosis models |
Electrophysiology
Patch-clamp and Ussing chamber techniques directly measure sodium currents and transepithelial transport. These methods are essential to quantify negative regulation of sodium ion transmembrane transport in real time [1,4]. For example, ENaC activity can be assessed in Xenopus oocytes or epithelial monolayers.
CRISPR Screening and Functional Genomics
Genome-wide CRISPR knockout or activation screens can identify genes that negatively regulate sodium transport. Libraries targeting ion channels, kinases, and ubiquitin ligases can be applied in high-throughput assays [1,6]. Hits are validated by secondary assays such as patch-clamp or ion flux measurements.
Transcriptomics and Proteomics
RNA-seq and mass spectrometry reveal changes in gene expression and protein abundance of sodium channels and regulators. For instance, SLC10A7 knockout alters glycosylation enzymes and calcium homeostasis, which can be monitored by proteomics. Phosphoproteomics can identify signaling events that modify ENaC or Na+/K+-ATPase.
Imaging and Trafficking Assays
Fluorescence microscopy and surface biotinylation track the localization of sodium channels and their regulators. These methods help determine whether negative regulation occurs via reduced surface expression or altered gating. Live-cell imaging can visualize dynamic changes in response to stimuli.
How CRISPR Can Be Used to Study GO:1902306 negative regulation of sodium ion transmembrane transport
Knockout
CRISPR knockout of candidate genes such as NEDD4L or SGK1 can reveal their role in negative regulation of sodium transport. For example, knocking out NEDD4L in epithelial cells would be expected to increase ENaC surface expression and sodium transport, confirming its negative regulatory function. Knockout models are also used to study ATP1A2 in neuroinflammation.
Point Mutation
Point mutations can mimic disease-associated variants or alter specific residues critical for regulation. For instance, mutating the negative charge in transmembrane segment 1 of a sodium channel can disrupt gating and negative regulation. CRISPR point-mutation knock-in allows precise modeling of such changes in endogenous loci.
Knock-in
Knock-in of tagged versions of sodium channels or regulators (e.g., GFP-ENaC) enables live-cell imaging and proteomic analysis. Knock-in of disease mutations, such as those in SCNN1B causing Liddle syndrome, provides physiologically relevant models to study loss of negative regulation.
Overexpression
Overexpression of negative regulators like NEDD4L or SGK1 can suppress sodium transport, offering a gain-of-function approach to study the pathway. Overexpression of TMEM16A in cystic fibrosis models can compensate for CFTR loss and modulate sodium transport indirectly.
How EDITGENE Supports negative regulation of sodium ion transmembrane transport Research
Researchers studying negative regulation of sodium ion transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in the process or is merely correlated. CRISPR-based cell models provide the gold standard for establishing causality, and EDITGENE offers a comprehensive suite of services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of sodium ion transmembrane transport research.
Frequently Asked Questions About negative regulation of sodium ion transmembrane transport
What is GO:1902306?
GO:1902306 is the Gene Ontology term for negative regulation of sodium ion transmembrane transport, defined as any process that stops, prevents, or reduces the frequency, rate, or extent of sodium ion transmembrane transport.
What genes are involved in negative regulation of sodium ion transmembrane transport?
Key genes include SCNN1A/B/G (ENaC subunits), ATP1A2 (Na+/K+-ATPase), CFTR, NEDD4L, SGK1, and SLC10A7, among others [1,2,5,6].
How is sodium ion transmembrane transport negatively regulated?
It can be regulated by direct channel inhibition, altered trafficking, post-translational modifications like glycosylation, and changes in ion gradients via ATPase regulation [1,4,5,7].
What diseases are associated with defective negative regulation of sodium transport?
Cystic fibrosis, Liddle syndrome, neuroinflammation, and congenital disorders of glycosylation are linked to dysregulation of this process [1,2,5,6].
Which experimental methods study GO:1902306?
Patch-clamp electrophysiology, Ussing chamber, CRISPR screens, RNA-seq, proteomics, and imaging are commonly used [1,2,4,5].
What is the role of ENaC in sodium transport regulation?
ENaC mediates sodium reabsorption in epithelia, and its activity is negatively regulated by anionic phospholipids, ubiquitination, and other signals.
How does CFTR affect sodium transport?
CFTR interacts with ENaC and regulates its activity; loss of CFTR in cystic fibrosis leads to enhanced sodium absorption [5,8].
Can CRISPR be used to study negative regulation of sodium transport?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect causal roles of genes in this process [1,4,6].
What is the role of glycosylation in sodium transport?
Glycosylation and sialylation of ion channels can modulate their function and surface expression, affecting sodium transport [2,7].
How does neuroinflammation relate to sodium transport?
The alpha-2 Na+/K+-ATPase isoform mediates LPS-induced neuroinflammation, and its regulation affects sodium gradients and neuronal function.
Conclusion
GO:1902306, negative regulation of sodium ion transmembrane transport, is a fundamental biological process with broad implications for human health and disease. From epithelial sodium channels to neuronal ATPases, the mechanisms that dampen sodium flux are diverse and tightly controlled. Dysregulation contributes to cystic fibrosis, hypertension, neuroinflammation, and glycosylation disorders. Advances in CRISPR-based models and functional genomics are accelerating the discovery of new regulators and therapeutic targets. EDITGENE stands ready to support researchers with tailored cell models and screening services to illuminate this critical pathway.
References
- 1. Ma HP et al.. 2005. Acute regulation of epithelial sodium channel by anionic phospholipids.. J Am Soc Nephrol 16(11):3182-7 PMID: 16192420
- 2. Durin Z et al.. 2025. SLC10A7 regulates O-GalNAc glycosylation and Ca(2+) homeostasis in the secretory pathway: insights into SLC10A7-CDG.. Cell Mol Life Sci 82(1):40 PMID: 39779512
- 3. Boedtkjer E et al.. 2016. Negative News: Cl- and HCO3- in the Vascular Wall.. Physiology (Bethesda) 31(5):370-83 PMID: 27511463
- 4. Du Y et al.. 2010. A negative charge in transmembrane segment 1 of domain II of the cockroach sodium channel is critical for channel gating and action of pyrethroid insecticides.. Toxicol Appl Pharmacol 247(1):53-9 PMID: 20561903
- 5. Lee JH et al.. 2007. Dynamic regulation of cystic fibrosis transmembrane conductance regulator by competitive interactions of molecular adaptors.. J Biol Chem 282(14):10414-22 PMID: 17244609
- 6. Leite JA et al.. 2020. The α(2) Na(+)/K(+)-ATPase isoform mediates LPS-induced neuroinflammation.. Sci Rep 10(1):14180 PMID: 32843655
- 7. Baycin-Hizal D et al.. 2014. Physiologic and pathophysiologic consequences of altered sialylation and glycosylation on ion channel function.. Biochem Biophys Res Commun 453(2):243-53 PMID: 24971539
- 8. Danahay H et al.. 2020. TMEM16A: An Alternative Approach to Restoring Airway Anion Secretion in Cystic Fibrosis?. Int J Mol Sci 21(7) PMID: 32235608
